EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Free Light Chain Monomer—Dimer Pattern Analysis as Non-Invasive Tool in Predicting MGUS and SMM Progression

Avshalom Serok, Lesya Olga Kukuy, Omer Shaked, Omer Weinstein iD, Marjorie Pick, Amir Serok, Alina Ostrovsky, Rivka Goldis, Eyal Lebel iD, Batia Kaplan iD, Moshe E Gatt iD

Cancers · 26.07.2026 · 18 (15) · 2409

DOI: 10.3390/cancers18152409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 26.07.2026. Verfasst von Avshalom Serok und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hadassah Medical Center, The Hebrew University of Jerusalem, Jerusalem 91120, Israel. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Cancer Association, Israeli Cancer Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: MGUS and smoldering multiple myeloma (SMM) are precursor states of plasma cell disorders with variable risk of progression to multiple myeloma (MM). Yet, current risk stratification models combine clinical and laboratory parameters, including invasive bone marrow assessment, but have limited precision.

Methods

We applied free light chain (FLC)-monomer (M)–dimer (D) pattern analysis (FLC-MDPA), a non-invasive Western blot–based serum assay, to detect abnormal FLC M–D patterns associated with early malignant transformation, for predicting progression in MGUS (n = 68) and SMM (n = 40). Among 96 patients with complete data, 50 formed a training set to define criteria for progressive disease and 46 comprised a validation set.

Results

FLC-MDPA predicted biochemical progression (sensitivity 0.79, specificity 0.92, NPV 0.86; HR 19.96, 95% CI 4.31–92) and clinical progression (sensitivity 0.84, specificity 0.79; HR 13.5, 95% CI 3.68–49.64), with significantly higher progression rates in patients with abnormal patterns (p < 0.0001). Within this high-risk cohort, FLC-MDPA was associated with higher hazard ratios for both biochemical and clinical progression compared with the 2/20/20 model, while incorporation into a modified 2/20/MDPA model improved sensitivity and negative predictive value. In a multivariable model including MDPA and FLC ratio, MDPA was independently associated with both clinical (p = 0.001) and biochemical progression (p = 0.04).

Conclusions

These findings suggest that FLC-MDPA is a promising non-invasive tool for risk stratification in MGUS and SMM, improving sensitivity and negative predictive value while potentially reducing reliance on bone marrow–based assessment.

Schlagwörter

Stichwörter der Autor:innen

FLCMGUSSMMdimerizationprogression

Autor:innen und Institutionen

  • Department of Internal Medicine, Hadassah Medical Center, The Hebrew University of Jerusalem, Jerusalem 91120, Israel.
  • Institute of Nephrology and Hypertension, Sheba Medical Center, Ramat Gan 52621, Israel.
  • Department of Hematology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel.
  • The School of Computer Science and AI, Tel Aviv University, Tel Aviv 69978, Israel.
  • Institute of Hematology and Sheba Cancer Research Center, Sheba Medical Center, Ramat Gan 52621, Israel.
  • Department of Neurology, Sheba Medical Center, Ramat Gan 52621, Israel.

ORCID-Profile: Omer Weinstein, Eyal Lebel, Batia Kaplan, Moshe E Gatt

Förderung

  • Israel Cancer Association
  • Israeli Cancer Association

Zitieren

APA

Serok, A., Kukuy, L. O., Shaked, O., Weinstein, O., Pick, M., Serok, A., Ostrovsky, A., Goldis, R., Lebel, E., Kaplan, B., & Gatt, M. E. (2026). Free Light Chain Monomer—Dimer Pattern Analysis as Non-Invasive Tool in Predicting MGUS and SMM Progression. Cancers, 18(15), 2409. https://doi.org/10.3390/cancers18152409

Vancouver

Serok A, Kukuy LO, Shaked O, Weinstein O, Pick M, Serok A, et al. Free Light Chain Monomer—Dimer Pattern Analysis as Non-Invasive Tool in Predicting MGUS and SMM Progression. Cancers. 2026;18(15):2409. doi:10.3390/cancers18152409

BibTeX
@article{Serok2026,
  author = {Serok, Avshalom and Kukuy, Lesya Olga and Shaked, Omer and Weinstein, Omer and Pick, Marjorie and Serok, Amir and Ostrovsky, Alina and Goldis, Rivka and Lebel, Eyal and Kaplan, Batia and Gatt, Moshe E},
  title = {Free Light Chain Monomer—Dimer Pattern Analysis as Non-Invasive Tool in Predicting MGUS and SMM Progression},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {15},
  pages = {2409},
  doi = {10.3390/cancers18152409}
}
Kostenlos starten →